XOMA Corp Files 8-K on Asset Disposition
Ticker: XOMAP · Form: 8-K · Filed: Apr 3, 2024 · CIK: 791908
| Field | Detail |
|---|---|
| Company | Xoma Corp (XOMAP) |
| Form Type | 8-K |
| Filed Date | Apr 3, 2024 |
| Risk Level | medium |
| Pages | 5 |
| Reading Time | 6 min |
| Key Dollar Amounts | $0.0075, $0.05, $0.0001, $2.5879 |
| Sentiment | neutral |
Sentiment: neutral
Topics: asset-disposition, corporate-action, financial-statements
TL;DR
XOMA Corp filed an 8-K on 4/3/24 about asset disposition - check for details.
AI Summary
On April 3, 2024, XOMA Corporation filed an 8-K report detailing the completion of an acquisition or disposition of assets. The filing also includes information on other events and financial statements and exhibits. XOMA Corporation is incorporated in Delaware and its principal business is in Pharmaceutical Preparations.
Why It Matters
This filing indicates a significant corporate action by XOMA Corp, potentially impacting its asset base and future financial performance.
Risk Assessment
Risk Level: medium — Filings related to asset disposition can signal strategic shifts or financial restructuring, which may carry inherent risks.
Key Numbers
- 001-39801 — Commission File Number (Identifies XOMA Corp's filing with the SEC.)
- 52-2154066 — I.R.S. Employer Identification Number (Tax identification number for XOMA Corp.)
Key Players & Entities
- XOMA Corp (company) — Registrant
- Delaware (jurisdiction) — State of Incorporation
- April 3, 2024 (date) — Date of Earliest Event Reported
FAQ
What specific assets were acquired or disposed of by XOMA Corp?
The filing indicates the completion of an acquisition or disposition of assets, but the specific details of the assets involved are not provided in this summary.
What is the financial impact of this asset transaction on XOMA Corp?
The filing does not specify the financial impact of the asset transaction on XOMA Corp.
When did the event triggering this 8-K filing occur?
The earliest event reported in this filing occurred on April 3, 2024.
What is XOMA Corp's primary industry?
XOMA Corp's Standard Industrial Classification is Pharmaceutical Preparations [2834].
Where is XOMA Corp incorporated?
XOMA Corp is incorporated in Delaware.
Filing Stats: 1,573 words · 6 min read · ~5 pages · Grade level 14.1 · Accepted 2024-04-03 09:27:05
Key Financial Figures
- $0.0075 — nge on which registered Common Stock, $0.0075 par value XOMA The Nasdaq Global Ma
- $0.05 — ve Perpetual Preferred Stock, par value $0.05 per share XOMAP The Nasdaq Global M
- $0.0001 — nding shares of common stock, par value $0.0001 per share (the " Shares "), in exchange
- $2.5879 — e (the " Shares "), in exchange for (i) $2.5879 in cash per Share (the " Cash Amount ")
Filing Documents
- d793644d8k.htm (8-K) — 40KB
- d793644dex22.htm (EX-2.2) — 135KB
- 0001193125-24-085545.txt ( ) — 377KB
- xoma-20240403.xsd (EX-101.SCH) — 4KB
- xoma-20240403_def.xml (EX-101.DEF) — 14KB
- xoma-20240403_lab.xml (EX-101.LAB) — 23KB
- xoma-20240403_pre.xml (EX-101.PRE) — 15KB
- d793644d8k_htm.xml (XML) — 7KB
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits Exhibit No. Description 2.1+ Agreement and Plan of Merger between XOMA, Kinnate and Purchaser, dated February 16, 2024 (incorporated herein by reference to Exhibit 2.1 to Form 8-K filed by XOMA Corporation on February 16, 2024). 2.2 Contingent Value Rights Agreement, dated April 3, 2024, by and between XOMA Corporation, XRA 1 Corp., Broadridge Corporate Issuer Solutions, LLC and Fortis Advisors LLC. 99.1 Press Release issued by XOMA Corporation on April 3, 2024 (incorporated herein by reference to Exhibit (a)(5)(D) to the Schedule TO-T/A filed by XOMA Corporation on April 3, 2024). 104 Cover Page Interactive Data File (embedded within the Inline XBRL document). + Previously Filed
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. XOMA CORPORATION Date: April 3, 2024 By: /s/ Owen Hughes Name: Owen Hughes Title: Chief Executive Officer